Aquilus Pharmaceuticals
Business Services · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3H Gill St Ste 300, Woburn, Massachusett...Phone Number
(617) 759-6590Website
www.aquiluspharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Aquilus Pharmaceuticals
Aquilus Pharmaceuticals is a pre-series A biotech company focused on developing innovative treatments for neurodegenerative diseases, particularly Amyotrophic Lateral Sclerosis (ALS). They are advancing a first-in-class medication, AQU-118, which is an orally bioavailable inhibitor targeting matrix metalloproteinases associated with nerve damage. The company is committed to impactful research and development, with plans for clinical trials set to begin in 2026. Their mission is to improve the lives of patients affected by ALS through collaboration with the community and expert guidance.Explore more
Aquilus Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aquilus Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Aquilus Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Aquilus Pharmaceuticals had a recent Job posting/layoffs
Earning: See what the market has to say on Aquilus Pharmaceuticals recently announced quarterly report
Funding: Get notified immidiatlly once Aquilus Pharmaceuticals has new funding data
Check out if Aquilus Pharmaceuticals is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Aquilus Pharmaceuticals launches new products
Congratulate Masked Content for being promoted to Masked Content at Aquilus Pharmaceuticals
Check if Aquilus Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Aquilus Pharmaceuticals
Compare insights from companies similar to Aquilus Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Aquilus Pharmaceuticals is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Aquilus Pharmaceuticals is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Aquilus Pharmaceuticals.
Aquilus Pharmaceuticals Tech Stack
A closer look at the technologies used by Aquilus Pharmaceuticals
See more technologies
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Aquilus Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Aquilus Pharmaceuticals is a pre-series A biotech company focused on developing innovative treatments for neurodegenerative diseases, particularly Amyotrophic Lateral Sclerosis (ALS). They are advancing a first-in-class medication, AQU-118, which is an orally bioavailable inhibitor targeting matrix metalloproteinases associated with nerve damage. T... Read More
